Multiple sclerosis ”game changer” drug gets government subsidy in Australia

Melanie Row was enjoying a family holiday on the Gold Coast in 2016 when she noticed she didn't have control of her right thumb.The...
video

University of Calgary research using acne medication to combat MS

A Canadian clinical trial led by researchers at the University of Calgary's Hotchkiss Brain Institute (HBI), at the Cumming School of Medicine (CSM), shows...

Advanced Practice Providers Treat Significantly More of their Multiple Sclerosis Patients with Monoclonal Antibody...

Market access restrictions for high efficacy Multiple Sclerosis therapies may be hindering their ability to optimally treat their clinically complex, relapsing patients, according to...

Could Probiotics Help to Fight Multiple Sclerosis?

Breaking research from the Mayo Clinic uncovers a gut microbe that has the potential to treat autoimmune diseases, including multiple sclerosis. The intriguing findings...
video

Talking about Ocrevus (Ocrelizumab)

The Rocky Mountain Multiple Sclerosis Center is a patient and family-centered nonprofit organization that provides a comprehensive and integrated wellness approach to MS and...

Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS

SOURCE Novartis- Breakthrough Therapy designation can expedite the development and review of therapies for serious conditions- In a pivotal Phase III study, oral fingolimod...

Roche seeks partners for remyelination therapies

Roche Holding AG is seeking a partner with experimental drugs that might help repair the damage caused to the nervous system by multiple sclerosis...

Multiple Sclerosis: Are we close to a cure?

Hannah Nichols recently posed this question in Medical News Today, "Researchers are uncovering many potential treatment routes for MS. Could they be close to...

New Inroads Against Multiple Sclerosis

JAMA recently published their interviews with two MS Specaists focusing on the medical progress against multiple sclerosis (MS) in 2017 with the approval by the...

Phase 2 Trial of Ibudilast Shows Slowing of Brain Shrinkage in Progressive MS

Patients living with primary progressive multiple sclerosis have eagerly been awaiting the results from phase 2 of the ibudilast study. It is the hope...

Social Media

800FollowersFollow